Cancer prevalence among COVID-19 patients may be higher than previously reportedApril 13, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Home-based chemo skyrockets at one U.S. centerApril 10, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Conducting cancer trials amid the COVID-19 pandemicApril 8, 2020MelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerBreast Cancer
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Maintaining cancer care in the face of COVID-19April 1, 2020Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMultiple MyelomaMelanoma
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
How is oncology adapting to COVID-19?March 23, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Disruptions in cancer care in the era of COVID-19March 20, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumorsJanuary 31, 2020Genitourinary CancerMelanomaLung CancerHead & Neck/Thyroid CancersOncology
Sharp declines for lung cancer, melanoma deaths fuel record drop in cancer mortalityJanuary 16, 2020Lung CancerMelanomaOncology
Levothyroxine dose for checkpoint inhibitor toxicity may be too highNovember 4, 2019MelanomaLung CancerOncology
